632356-41-3

Basic information

• Product Name: methyl 3-amino-4-chlorothiophene-2-carboxylate
• Synonyms: methyl 3-amino-4-chlorothiophene-2-carboxylate
• CAS NO: 632356-41-3
• Molecular Formula: C6H6ClNO2S
• Molecular Weight: 191.63534
• Mol File: 632356-41-3.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 324.4±37.0 °C(Predicted)
• Appearance: /
• Density: 1.462±0.06 g/cm3(Predicted)
• PKA: -0.09±0.10(Predicted)
• CAS DataBase Reference: methyl 3-amino-4-chlorothiophene-2-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 3-amino-4-chlorothiophene-2-carboxylate(632356-41-3)
• EPA Substance Registry System: methyl 3-amino-4-chlorothiophene-2-carboxylate(632356-41-3)

Safety Data

• Hazardous Substances Data: 632356-41-3(Hazardous Substances Data)

Upstream product

• 22288-78-4 Methyl 3-aminothiophene-2-carboxylate 
• 22288-79-5 3-acetylamine-2-thiophenecarboxylic acid methyl ester 
• 632356-39-9 methyl 3-acetamido-4,5-dichlorothiophene-2-carboxylate 
• 161833-42-7 3-amino-4-bromo-2-thiophenecarboxylic acid methyl ester 

Downstream Products

• 632356-42-4 4-chlorothiophen-3-amine hydrochloride 

Relevant articles and documents

ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) MODULATORS AND USES THEREOF

Provided herein are small molecule modulators of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.

SUBSTITUTED THIENOIMIDAZOLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT OR DIAGNOSTIC AND MEDICAMENTS COMPRISING THE SAME

The invention relates to substituted thienoimidazoles of formula (I) or (II), where R1 to R4 have the meanings given in the claims. Medicaments comprising compounds of this type are useful for the prevention or treatment of diverse diseases. The compounds find application, amongst other things, for the treatment of breathing disorders and snoring, to improve the breathing process, for treatment of chronic and acute diseases of the kidney and the intestine, diseases caused by ischaemic and/or reperfusion events, proliferative or fibrotic diseases, for the treatment or prophylaxis of diseases of the central nervous system, lipometabolism, diabetes, blood clotting and parasitic attack.